NCT04254107 2025-02-10A Safety Study of SEA-TGT (SGN-TGT) in Advanced CancerSeagen Inc.Phase 1 Terminated133 enrolled
NCT02086604 2022-02-17Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell LymphomaWashington University School of MedicinePhase 1 Completed37 enrolled